![]() |
|||
|
|
|
|
| UPDATE: May 2008 | MW: 339.42 | MF: C20H21NO4 |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
other mutation test systems
|
mouse
other cell types
|
100 µmol/L
|
JIDEAE 66,313,1976
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intradermal | mouse
lethal dose (50 percent kill): 150 mg/kg
|
Behavioral: Excitement | Behavioral: Ataxia Lung, Thorax, or Respiration: Dyspnea
AIPTAK 59,149,1938
|
intramuscular | man
lowest published toxic dose: 1,143 µg/kg
|
Behavioral: Somnolence (general depressed activity) | Behavioral: Coma
EJCPAS 33,651,1988
|
intramuscular | mouse
lethal dose (50 percent kill): 175 mg/kg
|
N/R
|
AITEAT 15,415,1967
|
intraperitoneal | mouse
lethal dose (50 percent kill): 91 mg/kg
|
N/R
|
USXXAM #4738965
|
intraperitoneal | rat
lethal dose (50 percent kill): 59,600 µg/kg
|
N/R
|
ARZNAD 20,1338,1970
|
intravenous | mouse
lethal dose (50 percent kill): 25 mg/kg
|
Behavioral: Excitement | Behavioral: Ataxia Lung, Thorax, or Respiration: Dyspnea
AIPTAK 59,149,1938
|
intravenous | rat
lethal dose (50 percent kill): 13,300 µg/kg
|
N/R
|
ARZNAD 26,2172,1976
|
intravenous | rat
lowest published toxic dose: 5 mg/kg
|
Vascular: Measurement of regional blood flow
|
JCPCDT 35,630,2000
|
intravenous | rat
lowest published toxic dose: 1.697 mg/kg
|
Vascular: BP lowering not characterized in autonomic section
|
JMCMAR 44,2950,2001
|
intravenous | rabbit
lethal dose (50 percent kill): 25 mg/kg
|
Behavioral: Excitement | Behavioral: Ataxia Lung, Thorax, or Respiration: Dyspnea
AIPTAK 59,149,1938
|
intravenous | rabbit
lowest published toxic dose: 17.8 mg/kg
|
Blood: Change in clotting factors
|
FATOAO 49,48,1986
|
oral | man
lowest published lethal dose: 114.3 mg/kg
|
Behavioral: Convulsions or effect on seizure threshold | Behavioral: Coma Gastrointestinal: Nausea or vomiting
AJEMEN 21,245,2003
|
oral | mouse
lethal dose (50 percent kill): 162 mg/kg
|
N/R
|
THERAP 14,731,1959
|
oral | rat
lethal dose (50 percent kill): 325 mg/kg
|
N/R
|
ARZNAD 20,1338,1970
|
oral | rabbit
lowest published lethal dose: 190 mg/kg
|
N/R
|
HBAMAK 4,1289,1935
|
parenteral | frog
lowest published lethal dose: 225 mg/kg
|
Behavioral: Altered sleep time (including change in righting reflex) | Cardiac: Pulse rate decreased with fall in BP Gastrointestinal: Nausea or vomiting
JPETAB 25,35,1925
|
subcutaneous | cat
lowest published lethal dose: 120 mg/kg
|
N/R
|
FDWU** -,-,1931
|
subcutaneous | dog
lowest published lethal dose: 120 mg/kg
|
N/R
|
FDWU** -,-,1931
|
subcutaneous | frog
lowest published lethal dose: 140 mg/kg
|
N/R
|
HBAMAK 4,1289,1935
|
subcutaneous | mouse
lethal dose (50 percent kill): 170 mg/kg
|
N/R
|
AEPPAE 227,129,1955
|
subcutaneous | pigeon
lowest published lethal dose: 150 mg/kg
|
N/R
|
FDWU** -,-,1931
|
subcutaneous | rat
lethal dose (50 percent kill): 151 mg/kg
|
N/R
|
ARZNAD 20,1338,1970
|
subcutaneous | rabbit
lowest published lethal dose: 250 mg/kg
|
N/R
|
HBAMAK 4,1289,1935
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
TOXICOLOGY REVIEW
|
|
DIMON* 39,678,1993
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
| ||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: X4373 |
Number of Industries 1; Total Number of Facilities 17; Number of Occupations 2; Total Number of Employees Exposed 563; Total Number of Female Employees Exposed 481 | |||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
N/R
|
| ||
REFERENCES:
CODEN
|
|
REFERENCE
AEPPAE
|
Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.)
V.110-253, 1925-66. For publisher information, see NSAPCC.
|
AIPTAK
|
Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of
Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898-
|
AITEAT
|
Archivum Immunologiae et Therapiae Experimentalis. (Ars Polona, POB 1001, 00-068 Warsaw 1,
Poland) V.10- 1962-
|
AJEMEN
|
American Journal of Emergency Medicine. (WB Saunders, Philadelphia, PA) V.1- 1983-
|
ARZNAD
|
Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960
Aulendorf, Fed. Rep. Ger.) V.1- 1951-
|
DIMON*
|
Disease-a Month (Chicago : Year Book Publishers) V. 24- 1978-
|
EJCPAS
|
European Journal of Clinical Pharmacology. (Springer-Verlag New York, Inc., Service Center,
44 Hartz Way, Secaucus, NJ 07094) V.3- 1970-
|
FATOAO
|
Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O
Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939-
|
FDWU**
|
"Ueber die Wirkung Verschiedener Gifte Auf Vogel, Dissertation," Forchheimer, L.,
Pharmakologischen Institut der Universitat Wurzburg, Fed. Rep. Ger., 1931
|
HBAMAK
|
"Abdernalden's Handbuch der Biologischen Arbeitsmethoden." (Leipzig, Ger. Dem. Rep.)
|
JCPCDT
|
Journal of Cardiovascular Pharmacology. (Raven Press, 1140 Ave. of the Americas, New York, NY
10036) V.1- 1979-
|
JIDEAE
|
Journal of Investigative Dermatology. (Williams & Wilkins Co., 428 E. Preston St., Baltimore,
MD 21202) V.1- 1938-
|
JMCMAR
|
Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB
POB 57136, West End Stn., Washington, DC 20037) V.6- 1963-
|
JPETAB
|
Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E.
Preston St., Baltimore, MD 21202) V.1- 1909/10-
|
THERAP
|
Therapie. (Doin, Editeurs, 8, Place de l'Odeon, F-75006 Paris, France) V.1- 1946-
|
USXXAM
|
United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231)
|
| |